retatrutide peptide trials Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide peptide 20mg: complete dosing

What Clinical Evidence Shows About Teen GLP-1 Safety Recent pediatric studies hint at potential benefits but underscore the need for more research

Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia

The company plans to use the savings to invest in growth opportunities in diabetes and obesity. Novo Nordisk expects DKK 8 billion in net one-off restructuring costs

Lonely individuals tend to quickly become stressed and become especially susceptible to disease

N Engl J Med 2025;392:777-87.ArticlePubMed 118

Epilepsia 47 , 11361143 (2006)